2026 NPPES data Neuropathology Physician NPI 1720460637 D.O.
Verify on CMS →

ANNA KENNEY, D.O.

Neuropathology Physician in ROCHESTER, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
303
Medicare Part D claims · 71 beneficiaries · Neuropathology Physician avg: 358
Generic prescribing
88%
generic claims · 12% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

ANNA KENNEY, D.O. filed 303 Medicare Part D claims in 2023 as a Neuropathology Physician in ROCHESTER, New York, prescribing 88% generic.

303
Part D claims, 2023
88%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ANNA KENNEY, D.O.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

303 Top 43% higher than 57% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

ANNA KENNEY, D.O. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ANNA KENNEY, D.O.?

Quality data not reported

NPI registry status

Active

Issued 06/27/2015

NPI 1720460637

Primary specialty

Neuropathology Physician

Rare

337 US NPIs in this specialty

Medicare Part D claims

303 15% vs specialty avg

2023 prescription claims

Specialty avg: 358

Specialty distribution in New York

How Neuropathology Physician compares to other specialties among New York providers

New York providers

Neuropathology Physician share within New York

1. Neuropathology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Neuropathology Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Neuropathology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Neuropathology Physician ABMS/AOA estimate

Est. board-certified rate (Neuropathology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Neuropathology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ANNA KENNEY, D.O. appears in the CMS NPPES registry as a Neuropathology Physician provider holding D.O. credentials at 601 ELMWOOD AVE, ROCHESTER, NY, 14642, with a listed phone of (585) 273-1154. NPI 1720460637 was issued on 06/27/2015. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KENNEY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 303 prescription claims written by this provider, covering 71 Medicare beneficiaries and totaling roughly $14K in drug spend, split 12% brand-name and 88% generic by claim count, with an opioid prescribing rate of 60.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Neuropathology Physician is a narrow specialty nationwide, with 337 enrolled providers across 43 states and an average of 358 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

601 ELMWOOD AVE
ROCHESTER, NY 14642

Provider Details

NPI 1720460637
Specialty Neuropathology Physician
Credentials D.O.
Gender Female
NPI Issued 06/27/2015

Hospital and facility affiliations

Facilities where ANNA KENNEY, D.O. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

STRONG PALLIATIVE CARE GROUP
ROCHESTER, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to ANNA KENNEY, D.O.. To verify ANNA KENNEY, D.O.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

ANNA KENNEY, D.O. — brand share 12.0%
Specialty average (est.)

12% brand-name claims vs 88% generic, on 303 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

303
Total Claims
$14K
Total Drug Cost
71
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
326
Total Day Supply
8,187
Brand vs Generic
12% brand / 88% generic
Brand Drug Cost
$4K
Generic Drug Cost
$10K
Opioid Claims
182 (60.1% rate)

Patient Demographics

Average Patient Age
64.4 years
Avg HCC Risk Score
2.77
Gender Split
52% female / 48% male
Age Distribution
<65: 31, 65-74: 18, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ANNA KENNEY, D.O. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Oxycodone Hcl
51
Morphine Sulfate
42
Morphine Sulfate Er
Morphine Sulfate
26
Methadone Hcl
23
Gabapentin
19
Lorazepam
18
Methylphenidate Hcl
17
Fentanyl
16
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Neuropathology Physician Overview

How ANNA KENNEY, D.O. fits within the Neuropathology Physician landscape nationally.

337
Neuropathology Physician Providers in US
43
States with Neuropathology Physician
358
Avg Claims per Provider

ANNA KENNEY, D.O.'s 303 claims are below the specialty average of 358.

Nearby Neuropathology Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as KENNEY.

Compare Neuropathology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ANNA KENNEY, D.O.'s specialty?
ANNA KENNEY, D.O. specializes in Neuropathology Physician and practices in ROCHESTER, New York. Credentials: D.O..
How much does ANNA KENNEY, D.O. prescribe under Medicare Part D?
In 2023, ANNA KENNEY, D.O. wrote 303 Medicare Part D claims totaling $14K in drug costs for 71 beneficiaries.
Where is ANNA KENNEY, D.O. located?
ANNA KENNEY, D.O. is located at 601 ELMWOOD AVE, ROCHESTER, NY, 14642. Phone: (585) 273-1154.
What is ANNA KENNEY, D.O.'s NPI number?
ANNA KENNEY, D.O.'s National Provider Identifier (NPI) is 1720460637, issued on 06/27/2015.
Does ANNA KENNEY, D.O. prescribe more brand-name or generic drugs?
ANNA KENNEY, D.O.'s prescribing is 12% brand-name and 88% generic drugs by claim count, with $4K in brand drug costs.
Does ANNA KENNEY, D.O. prescribe opioids?
Yes, ANNA KENNEY, D.O. had 182 opioid claims in 2023 with an opioid prescribing rate of 60.1%.
How many Neuropathology Physician providers are there in the US?
There are 337 Neuropathology Physician providers across 43 states in the US. The average Neuropathology Physician provider writes 358 Medicare Part D claims per year.
What drugs does ANNA KENNEY, D.O. prescribe most often?
Based on 2023 Medicare Part D data, ANNA KENNEY, D.O.'s most frequently prescribed drugs include Oxycodone Hcl, Morphine Sulfate, Morphine Sulfate Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ANNA KENNEY, D.O. accept Medicare?
ANNA KENNEY, D.O. appears in CMS Medicare data with 303 Part D claims and 71 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ANNA KENNEY, D.O.'s credentials?
ANNA KENNEY, D.O.'s NPI is 1720460637 with credentials D.O.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology